Emphasizing the burden of proof: The American College of Cardiology 2008 Expert Panel Comments on the ENHANCE Trial

Circ Cardiovasc Qual Outcomes. 2010 Nov;3(6):565-7. doi: 10.1161/CIRCOUTCOMES.110.959577.

Author

Harlan M Krumholz¹

Affiliation

¹ Department of Medicine, Yale University School of Medicine, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Conn., USA. harlan.krumholz@yale.edu

PMID: 21081745
DOI: 10.1161/CIRCOUTCOMES.110.959577

No abstract available

MeSH terms

Anticholesteremic Agents / therapeutic use*
Atherosclerosis / drug therapy*
Atherosclerosis / pathology
Atherosclerosis / physiopathology
Azetidines / therapeutic use*
Biomarkers / metabolism
Cardiology*
Carotid Arteries / drug effects
Carotid Arteries / pathology
Clinical Trials Data Monitoring Committees
Clinical Trials as Topic
Evidence-Based Medicine
Expert Testimony
Ezetimibe
Humans
Hypercholesterolemia / prevention & control
Lipoproteins, LDL / metabolism
Simvastatin / therapeutic use*

Substances

Anticholesteremic Agents
Azetidines
Biomarkers
Lipoproteins, LDL
Simvastatin
Ezetimibe